FIELD: medicine, cardiology.
SUBSTANCE: the present innovation deals with treating patients with ischemic cardiac disease at the background of type II diabetes. For this purpose, in case of stenocardia of functional class II and type II diabetes of average severity degree one should introduce enalapril at the dosage of 20 mg/d in combination with trental at the dosage of 400 mg/d, and at stenocardia of functional class III and type II diabetes of severe flow one should introduce enalapril at the dosage of 30 mg/d in combination with trental at the dosage of 400 mg/d. The innovation suggested normalizes monocytic-macrophageal link of immune system.
EFFECT: higher efficiency of correction.
2 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS SUFFERING CHRONIC CARDIAC FAILURE COMPROMISED TYPE 2 DIABETES | 2010 |
|
RU2421218C1 |
METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION | 2010 |
|
RU2422136C1 |
METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME IN PATIENTS WITH ACUTE CORONARY SYNDROME AND CONCOMITANT TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2573499C1 |
METHOD FOR EVALUATING THE DEGREE OF THERAPY AND DETERMINING THE INDICATIONS FOR ANTIOXIDANT THERAPY IN PATIENTS WITH ISCHEMIC CARDIAC DISEASE | 2001 |
|
RU2192643C1 |
METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2428980C1 |
METHOD FOR CORRECTING COGNITIVE DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2555334C1 |
MEDICINAL PRODUCT FOR THE TREATMENT OF ULCER DEFECTS IN "DIABETIC FOOT" SYNDROME | 2023 |
|
RU2804781C1 |
METHOD FOR ASSESSING THE RISK OF UNFAVOURABLE OUTCOME OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2021 |
|
RU2790520C1 |
METHOD OF TREATING PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2543468C2 |
METHOD FOR DETERMINING RISK OF CORONARY ARTERY ATHEROSCLEROSIS IN PATIENTS SUFFERING FROM DIABETES MELLITUS ACCOMPANIED BY CARDIOVASCULAR DISORDERS | 2013 |
|
RU2532521C1 |
Authors
Dates
2006-06-27—Published
2004-10-18—Filed